Data / Form D filings / KannaLife Sciences, Inc.
KannaLife Sciences, Inc.: Form D filings
KannaLife Sciences, Inc., a pharmaceuticals company in West Hills, NY, filed 2 Form D notices with the SEC between 2012 and 2013. The latest, on April 30, 2013, reports $1.5 million sold of a $1.5 million offering to 2 investors.
Find out what KannaLife Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 363 West Hills Road, West Hills, NY, 11743
- Phone
- (516) 669-3219
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1538856
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2013 | New notice | $1,500,000 | $1,500,000 | $0 | 2 | Mar 4, 2013 | sec.gov |
| Feb 3, 2012 | New notice | $15,000,000 | $0 | $15,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Mona, Jr. | Director | |
| Mark Corrao | Executive Officer | |
| Dean Petkanas | Executive Officer, Director | |
| Stuart Titus | Director | |
| Thoma Kikis | Executive Officer, Director |
Other pharmaceuticals companies in New York that filed recently
- NBO Pharma Inc. $238,000 · Nov 9, 2026
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Apr 29, 2013 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what KannaLife Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.